• STAT+: Illumina has been ignoring its investors, but it can't ignore Carl Icahn

    17 days ago - By San Diego Biotechnology

    Illumina, the DNA sequencing giant whose stock has fallen 40% in two years, already had problems. Now it has to contend with Carl Icahn. The granddaddy of activist investors announced Monday morning that he's taken...
    Read more ...